Form 8-K - Current report:
SEC Accession No. 0001104659-20-077510
Filing Date
2020-06-26
Accepted
2020-06-26 17:00:15
Documents
1
Period of Report
2020-06-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2023455d1_8k.htm 8-K 15006
  Complete submission text file 0001104659-20-077510.txt   16538
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

EIN.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36641 | Film No.: 20994846
SIC: 2836 Biological Products, (No Diagnostic Substances)